|
August 1, 2008 ESP Portfolio Company --
EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene®I.V.
EKR is Introducing New Products Immediately
EKR Therapeutics is a specialty
pharmaceutical company committed to enhancing patient quality-of-life in the
acute setting, including pain management and oncology supportive care.
|
Home
Portfolio